Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › CRM1 inhibitors for treating epilepsy

CRM1 inhibitors for treating epilepsy

US Patent 11602530 · Granted Mar 14, 2023

Estimated economic value: $199,198,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Treating essential tremor using (R)-2-(4-Isopropylphenyl)-N-(1-(5-(2,2,2-Trifluo2025
Formulations of T-type calcium channel modulators and methods of use thereof2024
Formulations of T-type calcium channel modulators and methods of use thereof2022
Treating essential tremor using (R)-2-(4-Isopropylphenyl)-N-(1-(5-(2,2,2-trifluo2022
Heterocyclic inhibitors of the sodium channel2022
Method for the treatment of epilepsy, epileptogenesis, seizures or convulsions b2019
Method for the treatment of epilepsy, epileptogenesis, seizures or convulsions b2019
Function modifying NAv1.7 antibodies2018
Androstane and pregnane steroids with potent allosteric gaba receptor chloride i2018
Method of treating a patient for pain by administering an anti-ion channel antib2017
Androstane and pregnane steroids with potent allosteric GABA receptor chloride i2016
Methods of treating pain using function modifying NAv1.7 antibodies2016